Opportunities this week:

On Thursday after the bell, L’Oreal issued a very reassuring set of Q1 sales figures. Following this encouraging update, we reiterate our OVERWEIGHT rating with an unchanged price target of €415.
Over the past few weeks, there have been a number of company specific and macroeconomic developments that, in our view, should be viewed in a positive light for Grafton Group. OVERWEIGHT PT: £12.05
Last week GSK secured favourable recommendations from the US CDC’s Advisory Committee on Immunisation Practices (ACIP) for two key vaccines. OVERWEIGHT PT: £20.10.